Tradestie Institutional Equity Comparison Engine
CAH vs SNYR โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
CAH Overall Edge
CAH Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cardinal Health, Inc. (CAH) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while SNYR counters with relative strength in Valuation. Fundamentally, CAH trades at 22.6x Forward P/E with 1.3% operating margin (+5.5% YoY revenue) versus SNYR at 0.6x Forward P/E and -10.3% operating margin (-32.8% YoY). In options structure, CAH sits in BREAKOUT (59th %ile IV; Dealer Gamma Walls on Pro) against SNYR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
SNYR
CAH 22.6x vs SNYR 0.6x Fwd P/E
Growth & Margin Winner
CAH
Op Margin 1.3% vs -10.3% ยท YoY +5.5% vs -32.8%
Momentum & Technical Winner
CAH
1Y +31.5% vs -96.2% ยท 52W Pos 87% vs 1%
Options & Structure Winner
CAH
BREAKOUT (59th %ile IV) vs UNCLASSIFIED (N/A IV)
CAH
NYSE
Cardinal Health, Inc.
Wholesale-Drugs, Proprietaries & Druggists' Sundries
$272.81
+0.17% 1D
Market Cap
$62.9B
1M Return
+6.72%
1Y Return
+31.46%
Forward P/E
22.6x
Unified AI Score
42.7 / 100
HOLD
Tech 24.0
Fund 39.0
Flow 59.0
Mom 36.0
SNYR
NASDAQ
Synergy CHC Corp. Common Stock
Medicinal Chemicals & Botanical Products
$0.09
-67.02% 1D
Market Cap
$4.1M
1M Return
-16.28%
1Y Return
-96.15%
Forward P/E
0.6x
Unified AI Score
48.9 / 100
HOLD
Tech 55.0
Fund 39.0
Flow 50.0
Mom 60.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
CAH +31.46%
SNYR -96.15%
Spread: +105.2 pp (CAH Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | CAH Revenue | SNYR Revenue | CAH Op. Margin | SNYR Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2019 | $145.5B | $30M | 1.4% | -27.1% | CAH |
| FY2020 | $152.9B | N/A | -2.7% | N/A | CAH |
| FY2021 | $162.5B | N/A | 0.3% | N/A | CAH |
| FY2022 | $181.3B | N/A | -0.3% | N/A | CAH |
| FY2023 | $205.0B | $40M | 0.4% | 25.3% | SNYR |
| FY2024 | $226.8B | $30M | 0.5% | 16.7% | SNYR |
| FY2025 | $222.6B | $30M | 1.0% | -27.8% | CAH |
| FY2026 | $254.2B | N/A | 1.0% | N/A | CAH |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | CAH | SNYR | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $62.9B | $4.1M | Larger Scale | CAH |
| Trailing P/E Ratio Valuation | 35.2x | 0.6x | Lower Multiple | SNYR |
| Forward P/E Ratio Valuation | 22.6x | 0.6x | Lower Multiple | SNYR |
| Revenue Growth (YoY) Growth | +5.5% | -32.8% | Higher Growth | CAH |
| Operating Margin (TTM) Profitability | 1.3% | -10.3% | Higher Margin | CAH |
| Net Profit Margin Profitability | 0.7% | -57.0% | Higher Margin | CAH |
| Return on Equity (ROE) Capital Efficiency | 0.0% | -361.1% | Higher ROE | CAH |
| 52-Week Range Position Momentum | 87% ($180โ$286) | 1% ($0โ$3) | Stronger Trend | CAH |
| Beta / 30D Volatility Risk Regime | -0.03ฮฒ ยท 24% Vol | -0.86ฮฒ ยท 868% Vol | Lower Realized Risk | CAH |
| Unified Institutional Score Composite Signal | 42.7 / 100 (HOLD) | 48.9 / 100 (HOLD) | Higher Composite | SNYR |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full CAH vs SNYR Buy Guide
CAH
BREAKOUT
97d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
59th %ile
IV Regime
Balanced (25thโ60th %ile)
SNYR
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither CAH nor SNYR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.